Chris Spivey

Chris Spivey is the editorial director of BioPharm International.


Navigating Challenges and Embracing Opportunities to Optimize mRNA Therapies

The discussion covers the challenges of optimizing mRNA therapies, including the diverse behaviors of mRNA in biological systems, as well as the opportunities presented by emerging mRNA technologies like circular and self-amplifying RNAs, and the role of regulators in ensuring quality control of these novel products.

Lessons from Vaccine Development and Future Possibilities

The panel discusses the rapid development of mRNA vaccines, the opportunities for mRNA technology to revolutionize drug discovery and gene therapy, and the need for regulatory collaboration to enable efficient review and access to these innovative treatments.